Educational campaign
OtherMultilevel educational campaign on stroke sympton recognition and the need for calling the Emergency Services
Other names: Community campaign, Public campaign
NCT Number: NCT01881152
The starting hypothesis is that a multilevel educational campaign, specifically developed for the local community, can increase public stroke awareness and reduce pre-hospital delay.
The effectiveness of such intervention will be evaluated according to a cluster randomized, stepped wedged design. The clusters are the four communities of the Area Vasta Emilia Nord, AVEN (Parma, Piacenza, Modena e Reggio Emilia). As analysis Units, we will consider the patients consecutively admitted to the six participating hospitals throughout the study period, for suspected stroke or transitory ischemic attack (TIA).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
AUSL Parma, Fidenza, Italy
After a baseline 3 month period, the educational campaign will be sequentially launched in the four communities over four 3 month periods, according to a computer-generated list. The comparison will be the"usual care".
Primary outcome measures: The proportion of patients arriving at the Emergency Department (ED) with suspected stroke or TIA within two hours.
Secondary outcome measures: the proportion of patients with confirmed stroke or TIA diagnosis; the proportion of ischemic stroke patients evaluated for recominanat Tissue Plasminogen Activator (rTPA) therapy; the proportion of patients treated with rTPA; time interval between arrival at the ED and CT scan; for patients treated with rTPA, time interval between arrival at the ED and therapy initiation (door to needle time); death and disability (assessed as modified Rankin Score 3-5) at 1 and 3 month from stroke onset.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Multilevel educational campaign on stroke sympton recognition and the need for calling the Emergency Services
Other names: Community campaign, Public campaign
Information on stroke usually delivered at the community level.
Time frame: Time interval from stroke onset to arrival at the Emergency Department
Proportion of patients arriving to the Emergency Department with suspected stroke or TIA within two hours
Time frame: 1 month from stroke onset
Death or disability (modified Rankin Scale 3-6)at 1 month
Time frame: 3 months from stroke onset
Death or disability (modified Rankin Scale 3-6) at 3 months
Time frame: Up to 4 hours and 30 minutes from stroke onset
Proportion of patients given thrombolysis
Time frame: Up to 3 hours from stroke onset
Proportion of patients evaluated for thrombolysis
Time frame: Up to 12 hours from admission at the ED
Time interval between arrival at the Emergency Department and CT scan
Time frame: Up to 4 hours and 30 minutes from stroke onset
Time interval between arrival at the ED and thrombolysis initiation
Azienda Ospedaliero-Universitaria di Parma
Other
Cluster Randomized Controlled Trial to Assess the Effectiveness of a Population-based Educational Campaign on Stroke Symptom Recognition in Reducing Pre-hospital Delay
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02368145
Acute Stroke, Brain Diseases
New Brunswick, New Jersey, United States
View Trial DetailsNCT07295366
Acute Stroke, Arterial Occlusive Diseases
Xuzhou, Jiangsu, China
View Trial DetailsNCT02900833
Acute Stroke, Brain Diseases
Paris, France
View Trial DetailsNCT05998902
Acute Stroke, Brain Diseases
Chongqing, Chongqing Municipality, China
View Trial Details